らんま丸
liked
$Metaplanet(3350.JP$
It's been moving since morning, and it's interesting to watch
Even if you get jittery, you can't do anything for a small beginner, so let's wait and see for a while
It's been moving since morning, and it's interesting to watch
Even if you get jittery, you can't do anything for a small beginner, so let's wait and see for a while
Translated
8
1
らんま丸
liked
Research results on Eisai's dementia drug lecanemab being highly effective with continuous use
July 31, 2024 9:22 AM GMT+9
Research results showing that the effects of the Alzheimer's disease treatment drug “lecanemab,” which were jointly developed by Eisai and US Biogen, increased with continuous use on early-stage patients, and that there were no new safety issues were presented at the Alzheimer's Association's international conference held in Philadelphia, USA on the 30th.
When effects were investigated on approximately 95% of clinical investigators who continued treatment, the decline in cognitive function was suppressed by 31% compared to patients who did not receive treatment after 3 years.
Also, no new safety issues have been identified during the past 3 years. According to Christopher Van Dyke of the Yale University Alzheimer's Disease Research Team, symptoms such as brain swelling and bleeding associated with lecanemab mainly occurred within 6 months of starting treatment. Recanemab has the function of removing amyloid from the brain.
Lin Kramer, Eisai's chief clinical officer, stated in an interview with Reuters that “it is definitely more effective in the long term than in the short term.”
July 31, 2024 9:22 AM GMT+9
Research results showing that the effects of the Alzheimer's disease treatment drug “lecanemab,” which were jointly developed by Eisai and US Biogen, increased with continuous use on early-stage patients, and that there were no new safety issues were presented at the Alzheimer's Association's international conference held in Philadelphia, USA on the 30th.
When effects were investigated on approximately 95% of clinical investigators who continued treatment, the decline in cognitive function was suppressed by 31% compared to patients who did not receive treatment after 3 years.
Also, no new safety issues have been identified during the past 3 years. According to Christopher Van Dyke of the Yale University Alzheimer's Disease Research Team, symptoms such as brain swelling and bleeding associated with lecanemab mainly occurred within 6 months of starting treatment. Recanemab has the function of removing amyloid from the brain.
Lin Kramer, Eisai's chief clinical officer, stated in an interview with Reuters that “it is definitely more effective in the long term than in the short term.”
Translated
5
らんま丸
liked
らんま丸
liked
$Direxion Daily Semiconductor Bull 3x Shares ETF(SOXL.US$
AMD's financial results are good, and N is rising, but there is no change in the fact that they are creating a downtrend staircase
Unless it recovers 111.5 and breaks through 116.5, unfortunately it is still on a downward trend
So far, 106 to 111.5If it doesn't rise again, we can also see 96, 92, 80
The 90 cars that were not visible at the time of posting yesterday's predictions began to be seen after opening
Meta financial results and the unemployment rate may be the biggest mountain range
AMD's financial results are good, and N is rising, but there is no change in the fact that they are creating a downtrend staircase
Unless it recovers 111.5 and breaks through 116.5, unfortunately it is still on a downward trend
So far, 106 to 111.5If it doesn't rise again, we can also see 96, 92, 80
The 90 cars that were not visible at the time of posting yesterday's predictions began to be seen after opening
Meta financial results and the unemployment rate may be the biggest mountain range
Translated
13
1
らんま丸
liked
Focus: Major global companies cut full-year forecasts, high interest rates and China's slump weigh
July 31, 2024 6:51 AM GMT+9 (some excerpts)
Major global companies have lowered their full-year earnings forecasts. The fact that high interest rates and the slump in the Chinese economy are putting pressure on consumer sentiment cast a dark shadow over the profit increase settlement for the second quarter.
Investors were disappointed with the financial results of many major companies such as McDonald's, Nissan, Tesla, Nestle, and Unilever. Approximately 40% of American and European companies announced financial results, but profits were almost as expected. However, it seems that financial results “almost as expected” have led to disappointment among investors only after global stock prices have risen drastically.
July 31, 2024 6:51 AM GMT+9 (some excerpts)
Major global companies have lowered their full-year earnings forecasts. The fact that high interest rates and the slump in the Chinese economy are putting pressure on consumer sentiment cast a dark shadow over the profit increase settlement for the second quarter.
Investors were disappointed with the financial results of many major companies such as McDonald's, Nissan, Tesla, Nestle, and Unilever. Approximately 40% of American and European companies announced financial results, but profits were almost as expected. However, it seems that financial results “almost as expected” have led to disappointment among investors only after global stock prices have risen drastically.
Translated
6
らんま丸
liked
$NVIDIA(NVDA.US$
I was watching the 102 yen level just now, so I feel like it's rising a lot now
The reality that it's over -5% doesn't change
I was watching the 102 yen level just now, so I feel like it's rising a lot now
The reality that it's over -5% doesn't change
Translated
7
らんま丸
liked
$NVIDIA(NVDA.US$
Because it has dropped by 7
Go up at least 7 ^ ^
I wish the settlement date was a little closer
Because it has dropped by 7
Go up at least 7 ^ ^
I wish the settlement date was a little closer
Translated
2
らんま丸
liked
Morgan Stanley's chief global economist said that although private consumption in the US will slow down, it is expected to stabilize thereafter.
Seth B. Carpenter stated in Morgan Stanley's note for North America that the Federal Reserve (Fed) would welcome an economic slowdown as inflation continues to decline due to post-Covid normalization.
“For the Federal Reserve, the economic slowdown is not a bug, but a feature. “Private consumption will slow down this year, but it will recover from last year's unsustainable high pace.
Meanwhile, while the US is decelerating from exceptionally strong private consumption growth, Europe is normalizing from exceptionally weak growth. Downside risks still remain, but full employment, rising wages, and falling inflation are working in their favor.
“Although Europe is not as dependent on consumption as the US, it is still a consumer-driven economy. Therefore, even if the part of the economy where the market tends to be more interested is weak, the difference in PMI between the manufacturing industry and the service industry shows exactly this,” Carpenter wrote.
Consumption trends in China are still soft, and analysts say under current policies...
Seth B. Carpenter stated in Morgan Stanley's note for North America that the Federal Reserve (Fed) would welcome an economic slowdown as inflation continues to decline due to post-Covid normalization.
“For the Federal Reserve, the economic slowdown is not a bug, but a feature. “Private consumption will slow down this year, but it will recover from last year's unsustainable high pace.
Meanwhile, while the US is decelerating from exceptionally strong private consumption growth, Europe is normalizing from exceptionally weak growth. Downside risks still remain, but full employment, rising wages, and falling inflation are working in their favor.
“Although Europe is not as dependent on consumption as the US, it is still a consumer-driven economy. Therefore, even if the part of the economy where the market tends to be more interested is weak, the difference in PMI between the manufacturing industry and the service industry shows exactly this,” Carpenter wrote.
Consumption trends in China are still soft, and analysts say under current policies...
Translated
5
らんま丸
liked
$Direxion Daily NVDA Bull 2X Shares(NVDU.US$ soon - half price - half price - exit is on the right
Translated
2
らんま丸
liked
$Chipotle Mexican Grill(CMG.US$
If you think it's going to go down with NVDA, does that mean it's going up?
If you think it's going to go down with NVDA, does that mean it's going up?
Translated
2